Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-076457
Filing Date
2007-12-19
Accepted
2007-12-19 11:59:02
Documents
2
Period of Report
2007-12-17

Document Format Files

Seq Description Document Type Size
1 INITIAL OWNERSHIP rrd183342.html 3  
1 INITIAL OWNERSHIP rrd183342.xml 3 1594
2 POWER OF ATTORNEY rrd162785_184014.htm EX-24. 3079
  Complete submission text file 0001181431-07-076457.txt   6601
Mailing Address 61 MOULTON ST CAMBRIDGE MA 02138
Business Address 61 MOULTON ST CAMBRIDGE MA 02138 6178760086
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVE, SUITE 1609 NEW YORK NY 10170
Business Address C/O ALFACELL CORP 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 2122970010
CARTER STEPHEN (Reporting) CIK: 0001135217 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30347 | Film No.: 071315535